- Home
- RVMD vs VMC Comparison
RVMD vs VMC Comparison
Compare RVMD & VMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RVMD | VMC |
|---|---|---|
| Founded | 2014 | 1909 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Mining & Quarrying of Nonmetallic Minerals (No Fuels) |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.3B | 36.2B |
| IPO Year | 2020 | 2007 |
Fundamental Metrics
Financial Performance| Metric | RVMD | VMC |
|---|---|---|
| Price | $183.99 | $283.66 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 25 | 24 |
| Target Price | $258.84 | ★ $312.00 |
| AVG Volume (30 Days) | ★ 1.9M | 1.3M |
| Earning Date | 11-04-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 0.70% |
| EPS Growth | N/A | ★ 18.39 |
| EPS | N/A | ★ 6.53 |
| Revenue | N/A | ★ $7,781,900,000.00 |
| Revenue This Year | N/A | $1.06 |
| Revenue Next Year | $526.64 | $5.10 |
| P/E Ratio | ★ N/A | $45.59 |
| Revenue Growth | N/A | ★ 6.38 |
| 52 Week Low | $58.91 | $237.03 |
| 52 Week High | $224.31 | $331.09 |
Technical Indicators
Market Signals| Indicator | RVMD | VMC |
|---|---|---|
| Relative Strength Index (RSI) | 56.58 | 76.47 |
| Support Level | $198.91 | $294.72 |
| Resistance Level | $207.50 | $302.14 |
| Average True Range (ATR) | 8.24 | 7.41 |
| MACD | 1.42 | 3.99 |
| Stochastic Oscillator | 86.26 | 96.13 |
Price Performance
Historical ComparisonAbout RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.
About VMC Vulcan Materials Company (Holding Company)
Vulcan Materials is the United States' largest producer of construction aggregates (crushed stone, sand, and gravel). Its largest markets include Texas, California, Virginia, Tennessee, Georgia, Florida, North Carolina, and Alabama. In 2024, Vulcan sold 219.9 million tons of aggregates, 13.6 million tons of asphalt mix, and 3.6 million cubic yards of ready-mix. As of Dec. 31, 2024, the company had 16.5 billion tons of aggregate reserves.